Recent progress in cancer cell membrane-based nanoparticles for biomedical applications

Immune clearance and insufficient targeting have limited the efficacy of existing therapeutic strategies for cancer. Toxic side effects and individual differences in response to treatment have further limited the benefits of clinical treatment for patients. Biomimetic cancer cell membrane-based nano...

Full description

Bibliographic Details
Main Authors: Qixiong Lin, Yueyou Peng, Yanyan Wen, Xiaoqiong Li, Donglian Du, Weibin Dai, Wei Tian, Yanfeng Meng
Format: Article
Language:English
Published: Beilstein-Institut 2023-02-01
Series:Beilstein Journal of Nanotechnology
Subjects:
Online Access:https://doi.org/10.3762/bjnano.14.24
_version_ 1827997329640128512
author Qixiong Lin
Yueyou Peng
Yanyan Wen
Xiaoqiong Li
Donglian Du
Weibin Dai
Wei Tian
Yanfeng Meng
author_facet Qixiong Lin
Yueyou Peng
Yanyan Wen
Xiaoqiong Li
Donglian Du
Weibin Dai
Wei Tian
Yanfeng Meng
author_sort Qixiong Lin
collection DOAJ
description Immune clearance and insufficient targeting have limited the efficacy of existing therapeutic strategies for cancer. Toxic side effects and individual differences in response to treatment have further limited the benefits of clinical treatment for patients. Biomimetic cancer cell membrane-based nanotechnology has provided a new approach for biomedicine to overcome these obstacles. Biomimetic nanoparticles exhibit various effects (e.g., homotypic targeting, prolonging drug circulation, regulating the immune system, and penetrating biological barriers) after encapsulation by cancer cell membranes. The sensitivity and specificity of diagnostic methods will also be improved by utilizing the properties of cancer cell membranes. In this review, different properties and functions of cancer cell membranes are presented. Utilizing these advantages, nanoparticles can exhibit unique therapeutic capabilities in various types of diseases, such as solid tumors, hematological malignancies, immune system diseases, and cardiovascular diseases. Furthermore, cancer cell membrane-encapsulated nanoparticles show improved effectiveness and efficiency in combination with current diagnostic and therapeutic methods, which will contribute to the development of individualized treatments. This strategy has promising clinical translation prospects, and the associated challenges are discussed.
first_indexed 2024-04-10T05:26:51Z
format Article
id doaj.art-595bc7ff3d864dc3ab2f1e5c6da88905
institution Directory Open Access Journal
issn 2190-4286
language English
last_indexed 2024-04-10T05:26:51Z
publishDate 2023-02-01
publisher Beilstein-Institut
record_format Article
series Beilstein Journal of Nanotechnology
spelling doaj.art-595bc7ff3d864dc3ab2f1e5c6da889052023-03-07T13:31:38ZengBeilstein-InstitutBeilstein Journal of Nanotechnology2190-42862023-02-0114126227910.3762/bjnano.14.242190-4286-14-24Recent progress in cancer cell membrane-based nanoparticles for biomedical applicationsQixiong Lin0Yueyou Peng1Yanyan Wen2Xiaoqiong Li3Donglian Du4Weibin Dai5Wei Tian6Yanfeng Meng7The Ninth Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030009, China Department of MRI, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China Department of MRI, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China Department of MRI, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China Department of MRI, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China Department of General Surgery, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, China Department of MRI, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China Immune clearance and insufficient targeting have limited the efficacy of existing therapeutic strategies for cancer. Toxic side effects and individual differences in response to treatment have further limited the benefits of clinical treatment for patients. Biomimetic cancer cell membrane-based nanotechnology has provided a new approach for biomedicine to overcome these obstacles. Biomimetic nanoparticles exhibit various effects (e.g., homotypic targeting, prolonging drug circulation, regulating the immune system, and penetrating biological barriers) after encapsulation by cancer cell membranes. The sensitivity and specificity of diagnostic methods will also be improved by utilizing the properties of cancer cell membranes. In this review, different properties and functions of cancer cell membranes are presented. Utilizing these advantages, nanoparticles can exhibit unique therapeutic capabilities in various types of diseases, such as solid tumors, hematological malignancies, immune system diseases, and cardiovascular diseases. Furthermore, cancer cell membrane-encapsulated nanoparticles show improved effectiveness and efficiency in combination with current diagnostic and therapeutic methods, which will contribute to the development of individualized treatments. This strategy has promising clinical translation prospects, and the associated challenges are discussed.https://doi.org/10.3762/bjnano.14.24cancer cell biomimeticsnanoparticlesprecision medicinetargeted therapytheranostic nanomedicine
spellingShingle Qixiong Lin
Yueyou Peng
Yanyan Wen
Xiaoqiong Li
Donglian Du
Weibin Dai
Wei Tian
Yanfeng Meng
Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
Beilstein Journal of Nanotechnology
cancer cell biomimetics
nanoparticles
precision medicine
targeted therapy
theranostic nanomedicine
title Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
title_full Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
title_fullStr Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
title_full_unstemmed Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
title_short Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
title_sort recent progress in cancer cell membrane based nanoparticles for biomedical applications
topic cancer cell biomimetics
nanoparticles
precision medicine
targeted therapy
theranostic nanomedicine
url https://doi.org/10.3762/bjnano.14.24
work_keys_str_mv AT qixionglin recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT yueyoupeng recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT yanyanwen recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT xiaoqiongli recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT dongliandu recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT weibindai recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT weitian recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications
AT yanfengmeng recentprogressincancercellmembranebasednanoparticlesforbiomedicalapplications